Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 32,470
-25 (-0.08%)
Sep 3, 2025, 11:30 AM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 687.55 billion as of September 2, 2025. Its market cap has increased by 19.59% in one year.
Market Cap
687.55B
Enterprise Value
658.38B
Revenue
65.90B
Ranking
n/a
PE Ratio
47.34
Stock Price
32,470.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 687.55B, an increase of 14,316.20%. That is a compound annual growth rate of 23.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 687.55B | 8.78% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | 334.90B | 20.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,750.88B |
| Divi's Laboratories | 1,617.50B |
| Cipla | 1,283.84B |
| Apollo Hospitals Enterprise | 1,094.20B |
| Mankind Pharma | 1,040.52B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 688.14B |
| Alkem Laboratories | 634.11B |